EN DE
STOCK COMPARISON

Chemclin Diagnostics Co. Ltd. A vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Chemclin Diagnostics Co. Ltd. A (688468) and Thermo Fisher Scientific (TMO) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Chemclin Diagnostics Co. Ltd. A trades at ¥6.53 versus a fair value of ¥1.21 (-81%), while Thermo Fisher Scientific trades at $678 versus $686 (+1%).
Chemclin Diagnostics Co. Ltd. A
688468.SHG · CNY · Health Care
-81%
upside to fair value
overvalued
Price¥6.53
Fair Value¥1.21
Quality49/100
Thermo Fisher Scientific
TMO · USD · Health Care
+1%
upside to fair value
fairly valued
Price$678
Fair Value$686
Quality62/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Chemclin Diagnostics Co. Ltd. AThermo Fisher Scientific
Valuation
72.6×P/E (TTM)36.6×
8.12×P/S (TTM)5.55×
1.87×P/B4.70× · book value is mostly goodwill
36.8×EV/EBITDA24.5×
n/aPEG1.74×
−81.5%Fair value upside+1.1%
2.2%Dividend yield0.3%
n/aDividend per share$1.80
Profitability
10%Operating margin18%
0.46×EBIT margin trend (5Y)0.74×
3%Return on equity14%
1%Return on assets5%
Growth
-10%Revenue growth (YoY)6%
-10.6%Avg. growth/yr (3Y)-0.3%
-4.5%Avg. growth/yr (5Y)6.7%
−19.3%Value creation/yr+2.6%
Balance & size
7.9×Interest coverage (EBIT/interest)5.7×
0.11×Debt / equity0.67×
$393MMarket cap$251B
weakGrowth qualityhealthy

Thermo Fisher Scientific leads: 3 to 11 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Chemclin Diagnostics Co. Ltd. Aof which business quality 51 · market factors 47 Thermo Fisher Scientificof which business quality 60 · market factors 82
ProfitabilityMargins and returns on capital today
28
43
Quality GrowthAre margins and returns improving?
6
31
CashflowEarnings quality: real cash, not paper profit
59
62
Fin. StrengthBalance sheet, leverage, solvency risk
75
60
InvestmentDisciplined investing over empire-building
60
79
Low VolatilityCalm price path (market factor)
87
69
MomentumPrice trend over the last 3–12 months (market factor)
35
84
52W MomentumDistance to the 52-week high (market factor)
24
92
Net IssuanceShare count: buybacks or dilution?
73
97

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyChemclin Diagnostics Co. Ltd. APrice ¥6.53Thermo Fisher ScientificPrice $678
DCF Models-82%below the price¥1.16-39%below the price$413
Earnings-Based-87%below the price¥0.84-70%below the price$204
Dividend Discount-82%below the price¥1.20n/a
Multiples-70%below the price¥1.94-54%below the price$310
Asset-Based-64%below the price¥2.36-86%below the price$96.78
Growth DCF-86%below the price¥0.91-47%below the price$361
Economic Profit-76%below the price¥1.56-74%below the price$177
Growth Earnings-72%below the price¥1.84-49%below the price$343
Minimum-87%below the price¥0.84-86%below the price$96.78
Maximum-64%below the price¥2.36-39%below the price$413
Median-79%below the price¥1.38-54%below the price$310
Geometric mean-79%below the price¥1.39-64%below the price$246

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Chemclin Diagnostics Co. Ltd. A: 24 of 24 models see the stock below the current price.

Thermo Fisher Scientific: 24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Chemclin Diagnostics Co. Ltd. A
Price ¥6.53
Fair Value ¥1.21
Bear ¥1.11Bull ¥1.86
Thermo Fisher Scientific
Price $678
Fair Value $686
Bear $414Bull $892

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Chemclin Diagnostics Co. Ltd. A · Health Care

Quality score49 · below median
Fair value upside-81% · bottom 25%

Thermo Fisher Scientific · Health Care

Quality score62 · above median
Fair value upside+1% · above median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Chemclin Diagnostics Co. Ltd. A trades at ¥6.53 versus a fair value of ¥1.21 (-81%), while Thermo Fisher Scientific trades at $678 versus $686 (+1%).

Thermo Fisher Scientific has the higher quality score (62/100).

Open Thermo Fisher Scientific live analysis →
Chemclin Diagnostics Co. Ltd. A · Thermo Fisher Scientific

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Chemclin Diagnostics Co. Ltd. A

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Thermo Fisher Scientific

Microsoft vs Taiwan Semiconductor ManufacturingBroadcom vs MicrosoftMicrosoft vs Micron TechnologyAdvanced Micro Devices vs Microsoft
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.